| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
124,228 | 158,052 | 143,136 | 203,477 | 176,759 |
| Cost of Revenue
|
-109,879 | -141,919 | -121,947 | -170,969 | -166,049 |
|
Gross Profit
|
14,349 | 16,133 | 21,189 | 32,508 | 10,710 |
|
Selling, General and Administrative Expenses
|
-14,636 | -15,021 | -16,303 | -20,705 | -16,592 |
| Depreciation, Amortization and Depletion
|
-552 | -661 | -661 | -664 | -725 |
|
Operating Income/Expenses
|
-15,188 | -15,682 | -16,964 | -21,369 | -17,317 |
|
Total Operating Profit/Loss
|
-839 | 451 | 4,225 | 11,139 | -6,607 |
| Total Net Finance Income/Expense
|
-2,967 | -3,386 | -3,078 | -3,201 | -3,218 |
| Irregular Income/Expenses
|
8,142 | 8,200 | 0 | -- | 0 |
|
Other Income/Expense, Non-Operating
|
78 | 64 | 79 | -48 | 130 |
|
Non-Operating Income/Expenses, Total
|
5,253 | 4,878 | -2,999 | -3,249 | -3,088 |
|
Pretax Income
|
4,414 | 5,329 | 1,226 | 7,890 | -9,695 |
|
Provision for Income Tax
|
-94 | -87 | -74 | -241 | -35 |
|
Net Income from Continuing Operations
|
4,320 | 5,242 | 1,152 | 7,649 | -9,730 |
|
Discontinued Operations
|
1,147 | -- | -- | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
5,467 | 5,242 | 1,152 | 7,649 | -9,730 |
|
Net Income after Non-Controlling/Minority Interests
|
5,467 | 5,242 | 1,152 | 7,649 | -9,730 |
|
Net Income Available to Common Stockholders
|
5,467 | 5,242 | 1,152 | 7,649 | -9,730 |
|
Diluted Net Income Available to Common Stockholders
|
5,467 | 5,242 | 1,152 | 7,649 | -9,730 |
| Basic EPS
|
0.23 | 0.23 | 0.05 | 0.36 | -0.48 |
| Diluted EPS
|
0.23 | 0.23 | 0.05 | 0.36 | -0.48 |
|
Basic Weighted Average Shares Outstanding
|
23,296.8810 | 22,872.8810 | 21,895.8470 | 21,188.6690 | 20,298.6410 |
|
Diluted Weighted Average Shares Outstanding
|
23,403.6910 | 22,979.6910 | 21,974.6290 | 21,491.2700 | 20,298.6410 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
7,381 | 8,715 | 4,304 | 11,091 | -6,477 |
|
EBITDA
|
13,740 | 15,025 | 10,988 | 17,474 | 775 |
|
Normalized EBITDA
|
5,901 | 8,699 | 13,325 | 21,474 | 2,444 |
|
Normalized Income
|
-10,191.2442 | -9,026 | 3,262.3000 | 9,840.8600 | -8,020.4400 |
|
Total Unusual Items
|
-14,827 | -14,500 | 2,245 | 2,255 | 2,164 |
|
Total Unusual Items Excluding Goodwill
|
-14,827 | -14,500 | 2,245 | 2,255 | 2,164 |
12/31/2022 - 11/10/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade